TABLE 2.

Comparison of genotyping results obtained by the four methods in genotype 1 specimens

Patient code	Genotyping result
	Direct NS5B sequencing	Versant HCV Genotype 2.0	Abbott Real time HCV genotype II	UDPS HCV Subtyping 454/GS-Juniora
P1–P17	1a	1a	1a	1a
P18–P61	1b	1b	1b	1b
P62	1a	1	1	1a
P63	1a	1a	1	1a
P64	1a	1	1a	1a
P65	1a	1a	1	1a
P66	1a	1	1	1a
P67	1a	1	1	1a
P68	1a	1	1	1a
P69	1a	1a	1	1a
P70	1b	1	1b	1b
P71	1b	1	1	1b
P72	1b	1	1b	1b
P73	1b	1	1b	1b
P74	1b	1	1b	1b
P75	1b	1	1	1b
P76	1b	1b	1	1b
P77	1b	1b	1b	1b + 3a + 1ab
P78	1b	1b	1	1b
P79	1b	1/1a	1b	1b
P80	1b	1	1b	1b
P81	1b	1b	1	1b
P82	1b	1b	1	1b

^aP < 0.001 for the comparison of UDPS with Versant HCV Genotype 2.0 and Abbott Real time HCV genotype II techniques.

^bSample with mixed infection. Relative proportions of subtypes: 1b, 43%; 3a, 35%; 1a, 20%.